Sophiris Bio

SHS-T

0.00
0.00 (0.00%)
This company is not ACTIVE.

Analysis and Opinions about SHS-T

Signal
Opinion
Expert
VAGUE
VAGUE
March 26, 2008
A drug that corrects complications that occur with the prostrate and prostrate cancer. Entering phase 2 clinical trials, has large market opportunities. Have done safety studies. In good shape regarding their cash position.
Show full opinionHide full opinion
Sophiris Bio (SHS-T)
March 26, 2008
A drug that corrects complications that occur with the prostrate and prostrate cancer. Entering phase 2 clinical trials, has large market opportunities. Have done safety studies. In good shape regarding their cash position.
Showing 1 to 1 of 1 entries
  • «
  • 1
  • »

Sophiris Bio(SHS-T) Rating

Ranking : 1 out of 5

Bullish - Buy Signals / Votes : 0

Neutral - Hold Signals / Votes : 0

Bearish - Sell Signals / Votes : 0

Total Signals / Votes : 0

Stockchase rating for Sophiris Bio is calculated according to the stock experts' signals. A high score means experts mostly recommend to buy the stock while a low score means experts mostly recommend to sell the stock.

Sophiris Bio(SHS-T) Frequently Asked Questions

What is Sophiris Bio stock symbol?

Sophiris Bio is a OTC stock, trading under the symbol SHS-T on the (). It is usually referred to as or SHS-T

Is Sophiris Bio a buy or a sell?

In the last year, there was no coverage of Sophiris Bio published on Stockchase.

Is Sophiris Bio a good investment or a top pick?

Sophiris Bio was never recommended as a Top Pick on Stockchase. Read the latest stock experts ratings for Sophiris Bio.

Why is Sophiris Bio stock dropping?

Earnings reports or recent company news can cause the stock price to drop. Read stock experts’ recommendations for help on deciding if you should buy, sell or hold the stock.

Is Sophiris Bio worth watching?

In the last year, there was no coverage of Sophiris Bio published on Stockchase.

What is Sophiris Bio stock price?

On , Sophiris Bio (SHS-T) stock closed at a price of $.